Skip to main content
Caplight Logo









IRegained

IRegained

Private
Greater SudburyHealthcare & Life Scienceshttps://iregained.us

Last Round

Grant

Apr 21, 2022

Total Funding Raised

$1.49M

Company Overview

IRegained operates in Healthcare & Life Sciences and is based in Greater Sudbury. Its latest recorded funding round was a Grant round in April 2022.

IRegained is a healthtech company that develops digital neurorehabilitation therapeutic devices to help patients regain hand function after a stroke or traumatic brain injury.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

IRegained Comparables

Compare IRegained with similar companies based on industry and business-model similarity.

IRegained comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GripAble
88%
Neurofenix
86%
Syrebo
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

IRegained Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 21, 2022
VC RoundMar 10, 2022
SeedJun 13, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

IRegained Investors

Notable investors and investment history

IRegained investors
InvestorRounds
Georgian Angel NetworkEarly Funding
Northern Ontario AngelsSeed
Archangel Network of FundsEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 23, 2025

    Generated $250,000 in sales since December 2024.

  • Dec 1, 2024

    MyHand System launched on December 1, 2024.

Book a demo to see all signals

For institutional investors. Book with your work email.

IRegained Filings

Explore SEC and related filing metadata, where available.

IRegained filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about IRegained's valuation, stock price, and market status.

Is IRegained a public or private company?

IRegained is a private company.

What is the current stock price of IRegained?

IRegained is a private company, so its shares have no public market price. Caplight tracks IRegained's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is IRegained worth (valuation)?

Valuation information for IRegained is not publicly available.

Can I buy IRegained stock?

IRegained shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was IRegained's last funding round?

IRegained's most recent funding round was Grant on April 21, 2022.

Who are the main investors in IRegained?

Key investors in IRegained include Northern Ontario Angels.

Will IRegained IPO soon?

No public IPO plans have been announced for IRegained.

How can I track IRegained secondary market activity?

Caplight tracks bids, offers, and trades in IRegained's shares on secondary markets.

Firmographic Details

HeadquartersGreater Sudbury
Employee Range13
Year Founded2016
Last FundingApr 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?